Low-Dose Acetylsalicylic Acid Analog and Acetazolamide for Prevention of Acute Mountain Sickness

被引:6
作者
Basnyat, Buddha [1 ]
Gertsch, Jeffry H. [1 ]
Holck, Peter C. [1 ]
机构
[1] Nepal Int Clin, Kathmandu, Nepal
关键词
D O I
10.1089/ham.2008.1060
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:349 / 349
页数:1
相关论文
共 3 条
[1]   Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: The prophylactic acetazolamide dosage comparison for efficacy (PACE) trial [J].
Basnyat, B ;
Gertsch, JH ;
Holck, PS ;
Johnson, EW ;
Luks, AM ;
Donham, BP ;
Fleischman, RJ ;
Gowder, DW ;
Hawksworth, JS ;
Jensen, BT ;
Kleiman, RJ ;
Loveridge, AH ;
Lundeen, EB ;
Newman, SL ;
Noboa, JA ;
Miegs, DP ;
O'Beirne, KA ;
Philpot, KB ;
Schultz, MN ;
Valente, MC ;
Wiebers, MR ;
Swenson, ER .
HIGH ALTITUDE MEDICINE & BIOLOGY, 2006, 7 (01) :17-27
[2]   Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial [J].
Basnyat, B ;
Gertsch, JH ;
Johnson, EW ;
Castro-Marin, F ;
Inoue, Y ;
Yeh, C .
HIGH ALTITUDE MEDICINE & BIOLOGY, 2003, 4 (01) :45-52
[3]   Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness [J].
Kayser, Bengt ;
Hulsebosch, Ronald ;
Bosch, Frank .
HIGH ALTITUDE MEDICINE & BIOLOGY, 2008, 9 (01) :15-23